Bormioli Rocco Pharma adds sales team for North American market

Complete line of products are FDA approved and will be made available in the US.

Bormioli Rocco Pharma, one of the world’s leading glass and plastic manufacturers, is strengthening its services in North America for pharmaceutical glass packaging with a dedicated sales team and innovative products, particularly for high-value parenteral drugs.

A market leader in its home country of Italy and co-leader in Europe, where the company has focused its sales and serves many pharmaceutical, biopharmaceutical and contract manufacturing organizations, Bormioli Rocco Pharma is now making its Delta molded Type I glass vials, and complete line of glass and plastic containers and closures, available in North America.

The company is a U.S. FDA-approved supplier of glass and plastic packaging for the pharma, biopharma, and CMO markets.
“As a validated international supplier of premium-quality glass and plastic pharmaceutical packaging, we are excited to introduce our solutions to North American customers with designated sales support,” said Stéphane Bis, Americas Regional Sales Manager at Bormioli Rocco Pharma. “We bring to the table long-term expertise in injectable pharmaceuticals packaging, as well as a complete range of integrated products matched by flexible, high-attention service.”

Bormioli Rocco Pharma’s Delta high-tech molded glass vials, available in a range of sizes and capacities, are optimal for today’s pharmaceutical injectables. As the pharmaceutical industry expands biologics such as antibodies, oligonucleotides and peptides, the active ingredients are more complex and sensitive, requiring specialized packaging that does not delaminate or leach contaminants. Delta products offer higher hydrolytic resistance and internal surface homogeneity to protect against delamination and ensure product stability.

To learn more about Bormioli Rocco Pharma’s North American sales and service strategy, contact Roberto Santovito, U.S. Sales Area Manager at